DEF: Tyra Biosciences Sets Date for 2025 Annual Stockholders Meeting

Tyra Biosciences announces its annual stockholders meeting to be held virtually on May 29, 2025, to elect directors and ratify the appointment of its independent accounting firm.

Summary

• Tyra Biosciences will hold its Annual Meeting of Stockholders virtually on May 29, 2025, at 10:00 a.m. Pacific Time.
• Stockholders of record as of April 4, 2025, are entitled to vote.
• The meeting will address the election of three Class I directors for a three-year term expiring at the 2028 Annual Meeting.
• The stockholders will also ratify the appointment of Ernst & Young LLP as the company's independent registered public accounting firm for the fiscal year ending December 31, 2025.
• The board recommends voting 'FOR' the election of the director nominees and 'FOR' the ratification of Ernst & Young LLP's appointment.

Sentiment

Score: 7

Explanation: The document is a standard proxy statement, presenting factual information and recommendations in a neutral tone. The sentiment is moderately positive as it reflects the company's adherence to corporate governance norms.

Positives

• The company is providing stockholders with electronic access to proxy materials, reducing costs and paper usage.
• Stockholders have multiple options for voting, including online, by phone, and by mail.
• The Audit Committee has pre-approved all audit and non-audit services provided by Ernst & Young LLP, ensuring auditor independence.

Future Outlook

The company plans to announce preliminary voting results at the Annual Meeting and report the final results in a Current Report on Form 8-K.

Management Comments

• Todd Harris, President and CEO, encourages stockholders to vote and submit their proxy promptly.
• The Board recommends voting 'FOR' the election of directors and the ratification of the accounting firm.

Industry Context

The document reflects standard corporate governance practices for publicly traded companies, including the solicitation of proxies and the holding of annual meetings.

Comparison to Industry Standards

• The virtual-only meeting format aligns with a growing trend among companies to leverage technology for shareholder engagement and cost efficiency.
• The disclosure of audit fees and the pre-approval process for audit and non-audit services are consistent with regulatory requirements and best practices for maintaining auditor independence.
• The director independence standards and committee structures are in line with Nasdaq listing requirements and corporate governance guidelines.

Stakeholder Impact

• Shareholders are asked to participate in the governance of the company by voting on key proposals.
• The outcome of the votes will influence the composition of the Board and the selection of the company's auditor.

Next Steps

• Stockholders are urged to vote their shares by phone, internet, or mail.
• The company will file a Form 8-K to report the final voting results after the Annual Meeting.

Key Dates

Keywords

Annual Meeting, Proxy Statement, Stockholders, Board of Directors, Director Election, Ernst & Young, Accounting Firm, Corporate Governance, TYRA, Tyra Biosciences